Plasma Neutrophil Gelatinase-Associated Lipocalin and Worsening Renal Function During Everolimus Therapy After Heart Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma Neutrophil Gelatinase-Associated Lipocalin and Worsening Renal Function During Everolimus Therapy After Heart Transplantation

Published:2015 Issue:1 Volume:56 Page:73-79
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Imamura Teruhiko¹,Kinugawa Koichiro¹,Doi Kent²,Hatano Masaru³,Fujino Takeo³,Kinoshita Osamu⁴,Nawata Kan⁴,Noiri Eisei⁵,Kyo Shunei¹,Ono Minoru⁴

Affiliation:

1. Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo

2. Department of Emergency and Critical Care Medicine, Graduate School of Medicine, University of Tokyo

3. Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo

4. Department of Thoracic Surgery, Graduate School of Medicine, University of Tokyo

5. Department of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference36 articles.

1. 1. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. J Heart Lung Transplant 2013; 32: 951-64.

2. 2. Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol 2013; 37: 602-12. (Review)

3. 3. Zuckermann A, Manito N, Epailly E, et al. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung Transplant 2008; 27: 141-9. (Review)

4. 4. Gullestad L, Iversen M, Mortensen SA, et al. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Transplantation 2010; 89: 864-72.

5. 5. Stypmann J, Engelen MA, Eckernkemper S, et al. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years’ follow-up from the University Hospital Münster. Transplant Proc 2011; 43: 1847-52.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Nomogram to Predict Contrast Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention;International Heart Journal;2017

2. Everolimus Attenuates Myocardial Hypertrophy and Improves Diastolic Function in Heart Transplant Recipients;International Heart Journal;2016

3. Long-Term Adaptive Servo-Ventilator Treatment Prevents Cardiac Death and Improves Clinical Outcome;International Heart Journal;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3